Mono Pharmacare Ltd

NSE: MONOPHARMA · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹8.40
Market cap: ₹14.84 Cr
Revenue (annual): ₹165.7 Cr
Net profit (annual): ₹0.73 Cr
P/E (TTM): 20.3×Sector 47.3×
Promoter holding: 56.72%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Management Change 4 Board Meeting Outcome 3 Board Meeting Date 3 Other Announcement 2 Legal & Regulatory 2

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

16 Jul 2026 18:36 IST NSE

Other Announcement

Mono Pharmacare Other Announcement

Mono Pharmacare Limited has appointed M/s. B G Kalal & CO as Internal Auditor for FY 2026-27. The board approved this based on Audit Committee recommendations.

Execution: Financial Year 2026-27

Read the filing ↗

28 May 2026 16:30 IST NSE

Other Announcement

Mono Pharmacare Other Announcement

Mono Pharmacare Limited filed a non-applicability confirmation for quarterly corporate governance reports. As an SME-listed entity, it remains exempt from Regulation 27(2) compliance requirements.

Read the filing ↗